Author Correction: Propensity of selecting mutant parasites for the antimalarial drug cabamiquine

• Eva Stadler,
• Mohamed Maiga,
• Lukas Friedrich,
• Vandana Thathy,
• Claudia Demarta-Gatsi,
• Antoine Dara,
• Fanta Sogore,
• Josefine Striepen,
• Claude Oeuvray,
• Abdoulaye A. Djimdé,
• Marcus C. S. Lee,
• Laurent Dembélé,
• David A. Fidock,
• David S. Khoury,
• Thomas Spangenberg

Affiliations

Eva Stadler

The Kirby Institute, UNSW Sydney

Mohamed Maiga

Université des Sciences, des Techniques et des Technologies de Bamako (USTTB), Faculté de Pharmacie, Malaria Research and Training Center (MRTC), Point G

Lukas Friedrich

Medicinal Chemistry & Drug Design Global Research & Development, Discovery Technologies, Merck Healthcare

Vandana Thathy

Department of Microbiology and Immunology, Columbia University Irving Medical Center

Claudia Demarta-Gatsi

Global Health Institute of Merck

Antoine Dara

Université des Sciences, des Techniques et des Technologies de Bamako (USTTB), Faculté de Pharmacie, Malaria Research and Training Center (MRTC), Point G

Fanta Sogore

Université des Sciences, des Techniques et des Technologies de Bamako (USTTB), Faculté de Pharmacie, Malaria Research and Training Center (MRTC), Point G

Josefine Striepen

Department of Microbiology and Immunology, Columbia University Irving Medical Center

Claude Oeuvray

Global Health Institute of Merck

Abdoulaye A. Djimdé

Université des Sciences, des Techniques et des Technologies de Bamako (USTTB), Faculté de Pharmacie, Malaria Research and Training Center (MRTC), Point G

Marcus C. S. Lee

Wellcome Sanger Institute, Wellcome Genome Campus

Laurent Dembélé

Université des Sciences, des Techniques et des Technologies de Bamako (USTTB), Faculté de Pharmacie, Malaria Research and Training Center (MRTC), Point G

David A. Fidock

Department of Microbiology and Immunology, Columbia University Irving Medical Center

David S. Khoury

The Kirby Institute, UNSW Sydney

Thomas Spangenberg

Global Health Institute of Merck